OpenSaMD is a platform designed to assist in the commercialization of open source medical software by helping developers navigate regulatory approval processes, thus enabling their products to be clinically used. The platform focuses on connecting researchers, hospitals, and industry, improving the innovation-development-deployment loop. OpenSaMD emphasizes transparent collaboration, ensuring that developers retain copyright of their software even if modifications are made for new products. It supports the use and distribution of software in research, development, clinical trials, and commercialization, ultimately aiming to enhance patient care across the globe.
• regulatory approval assistance
• commercialization of open source software
• global market access for software
• retain copyright ownership
• facilitates collaboration between industry and research
OpenSaMD will undertake the regulatory approval for your software. Once it is approved by the relevant regulatory body, you may commence offering it as a commercial product.
OpenSaMD does not charge for any services. Instead, we enter into a revenue sharing agreement with you when you commercialise your product. We do not make any money unless you do.
Through the AGPL open source licence rules, you own the copyright to your code. This copyright to your portion of the code remains and extends to any products or software that builds upon your code.
Hospitals, research institutions and healthcare organisations around the world can download your software directly through OpenSaMD.
• No service charges
• Revenue sharing model upon commercialization
• Support for regulatory approval
• Global market access for software
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
A federated AI framework that integrates decentralized data sources for AI development.
View Details